These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18869371)

  • 1. [Considerations on oncology at the Hospital of Miliana, utility of an anticancer secretariat].
    SEROR J
    Bull Alger Carcinol; 1948; 1(2):132-7. PubMed ID: 18869371
    [No Abstract]   [Full Text] [Related]  

  • 2. Complementary and Integrative Medicine to Reduce Adverse Effects of Anticancer Therapy.
    Rossi E; Noberasco C; Picchi M; Stefano MD; Rossi A; Nurra L; Ventura L
    J Altern Complement Med; 2018; 24(9-10):933-941. PubMed ID: 30247968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive care and oncology.
    Sculier JP
    Support Care Cancer; 1995 Mar; 3(2):93-105. PubMed ID: 7773586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case reports & treatment of 59 patients attacked by epidemic jaundice hepatitis treated at Miliana].
    MINDUS A
    Bull Mens Soc Med Mil Fr; 1957 Dec; 51(10):428-32. PubMed ID: 13536647
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral anticancer therapy project: Clinical utility of a specific home care nursing programme on behalf of Italian Association of Medical Oncology (AIOM).
    Cirillo M; Carlucci L; Legramandi L; Baldini E; Sacco C; Zagonel V; Leo S; Di Fabio F; Tonini G; Meacci ML; Tartarone A; Farci D; Tortora G; Zaninelli M; Valori VM; Cinieri S; Carrozza F; Barbato E; Fabbroni V; Cretella E; Gamucci T; Lunardi G; Zamboni S; Micallo G; Cascinu S; Pinto C; Gori S
    J Clin Nurs; 2020 Jan; 29(1-2):119-129. PubMed ID: 31532035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Companion animals in comparative oncology: One Medicine in action.
    Garden OA; Volk SW; Mason NJ; Perry JA
    Vet J; 2018 Oct; 240():6-13. PubMed ID: 30268334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of systemic anticancer therapy for patients within the last 30 days of life: experience in a private hospital oncology group.
    Wein L; Rowe C; Brady B; Handolias D; Lipton L; Pook D; Stanley R; Haines I
    Intern Med J; 2017 Mar; 47(3):280-283. PubMed ID: 27658500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of physiologically based pharmacokinetic (PBPK) modeling in oncology drug development and its accuracy: a systematic review.
    Saeheng T; Na-Bangchang K; Karbwang J
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1365-1376. PubMed ID: 29978293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.
    Divakaruni A; Saylor E; Duffy AP
    J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cancer Rehabilitation: integrated in the care pathways of modern oncology].
    Strasser F
    Ther Umsch; 2019; 76(8):449-459. PubMed ID: 32096721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endpoints and other considerations in phase I studies of targeted anticancer therapy: recommendations from the task force on Methodology for the Development of Innovative Cancer Therapies (MDICT).
    Booth CM; Calvert AH; Giaccone G; Lobbezoo MW; Seymour LK; Eisenhauer EA
    Eur J Cancer; 2008 Jan; 44(1):19-24. PubMed ID: 17890079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution No. 44/75. Improvement of the Status of Women in the Secretariat, 8 December 1989.
    United Nations. General Assembly
    Annu Rev Popul Law; 1989; 16():136, 557-8. PubMed ID: 12344116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of a health insurance database to conduct pharmacoepidemiological studies in oncology.
    Conte C; Vaysse C; Bosco P; Noize P; Fourrier-Reglat A; Despas F; Lapeyre-Mestre M
    Therapie; 2019 Apr; 74(2):279-288. PubMed ID: 30824175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of use of oral anticancer treatments in France: a Retrospective Analysis of Cancer Treatments given ORally from 2004 to 2012 (Re-ACTOR study).
    Benjamin L; Maroun R; Maurel F; Bardoulat I; Ricarte C
    Curr Med Res Opin; 2015 Feb; 31(2):323-32. PubMed ID: 25383982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology.
    Abdelgawad IY; Grant MKO; Zordoky BN
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30875799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of two cancer organization websites for a multiethnic, public hospital oncology population: comparative cross-sectional survey.
    Nguyen KD; Hara B; Chlebowski RT
    J Med Internet Res; 2005 Jul; 7(3):e28. PubMed ID: 15998619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytochemicals in Anticancer Drug Development.
    Dutt R; Garg V; Khatri N; Madan AK
    Anticancer Agents Med Chem; 2019; 19(2):172-183. PubMed ID: 30398123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The concept of a Clinical Review Secretariat--evolution of a clinical review programme at Dandenong and District Hospital.
    Anastasios JJ; Zubevich J; Peek A
    Aust Clin Rev; 1988 Mar; 8(28):19-23. PubMed ID: 3365144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving paradigms for new agent development in pediatric oncology.
    Flynn A; Fox E
    Curr Opin Pediatr; 2018 Feb; 30(1):10-16. PubMed ID: 29176356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multidisciplinary review of nutrition considerations in the pediatric oncology population: a perspective from children's oncology group.
    Ladas EJ; Sacks N; Meacham L; Henry D; Enriquez L; Lowry G; Hawkes R; Dadd G; Rogers P
    Nutr Clin Pract; 2005 Aug; 20(4):377-93. PubMed ID: 16207678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.